Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any area of product development, commercialisation and early access programs, and life cycle management
The implementation of the European Medical Device Regulation, Regulation (EU) 2017/745 (MDR) and the publication of numerous guidelines could increase the already existing confusion about the association of medicinal product or medicinal substance with medical device. The objective of this whitepaper is to provide a support on the management of initial submission to EMA (European Medicines Agency) of such association according to version 1 of EMA Guideline recently
Thank you for your interest in BlueReg.
The file will be sent to you by email.